Cancer Genes and Networks
The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells
Erika Parasido, George S. Avetian, Aisha Naeem, Garrett Graham, Michael Pishvaian, Eric Glasgow, Shaila Mudambi, Yichien Lee, Chukwuemeka Ihemelandu, Muhammad Choudhry, Ivana Peran, Partha P. Banerjee, Maria Laura Avantaggiati, Kirsten Bryant, Elisa Baldelli, Mariaelena Pierobon, Lance Liotta, Emanuel Petricoin, Stanley T. Fricke, Aimy Sebastian, Joseph Cozzitorto, Gabriela G. Loots, Deepak Kumar, Stephen Byers, Eric Londin, Analisa DiFeo, Goutham Narla, Jordan Winter, Jonathan R. Brody, Olga Rodriguez and Chris Albanese
Erika Parasido
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
George S. Avetian
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Aisha Naeem
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Garrett Graham
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Michael Pishvaian
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Eric Glasgow
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Shaila Mudambi
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Yichien Lee
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Chukwuemeka Ihemelandu
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Muhammad Choudhry
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Ivana Peran
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Partha P. Banerjee
Department of Biochemistry, Molecular and Cell Biology, Georgetown University Medical Center, Washington, D.C.
Maria Laura Avantaggiati
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Kirsten Bryant
Department of Pharmacology, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina.
Elisa Baldelli
Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia.
Mariaelena Pierobon
Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia.
Lance Liotta
Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia.
Emanuel Petricoin
Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia.
Stanley T. Fricke
Center for Translational Imaging, Georgetown University Medical Center, Washington, D.C.
Aimy Sebastian
Biology and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California.
Joseph Cozzitorto
Division of Surgical Research, Department of Surgery, Jefferson Pancreas, Biliary and Related Cancer Center, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Gabriela G. Loots
Biology and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California.
Deepak Kumar
Department of Pharmaceutical Sciences, Julius L. Chambers Biomedical/Biotechnology Research Institute (JLC-BBRI), North Carolina Central University, Durham, North Carolina.
Stephen Byers
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Eric Londin
Computational Medicine Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Analisa DiFeo
Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Goutham Narla
Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Jordan Winter
Division of Surgical Research, Department of Surgery, Jefferson Pancreas, Biliary and Related Cancer Center, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.Case Western Reserve School of Medicine, Case Comprehensive Cancer Center and University Hospitals Cleveland Medical Center, Cleveland, Ohio.
Jonathan R. Brody
Division of Surgical Research, Department of Surgery, Jefferson Pancreas, Biliary and Related Cancer Center, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Olga Rodriguez
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.Center for Translational Imaging, Georgetown University Medical Center, Washington, D.C.
Chris Albanese
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.Center for Translational Imaging, Georgetown University Medical Center, Washington, D.C.
DOI: 10.1158/1541-7786.MCR-19-0191 Published September 2019

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't.
September 2019
Volume 17, Issue 9
Volume 17, Issue 9
The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells
Erika Parasido, George S. Avetian, Aisha Naeem, Garrett Graham, Michael Pishvaian, Eric Glasgow, Shaila Mudambi, Yichien Lee, Chukwuemeka Ihemelandu, Muhammad Choudhry, Ivana Peran, Partha P. Banerjee, Maria Laura Avantaggiati, Kirsten Bryant, Elisa Baldelli, Mariaelena Pierobon, Lance Liotta, Emanuel Petricoin, Stanley T. Fricke, Aimy Sebastian, Joseph Cozzitorto, Gabriela G. Loots, Deepak Kumar, Stephen Byers, Eric Londin, Analisa DiFeo, Goutham Narla, Jordan Winter, Jonathan R. Brody, Olga Rodriguez and Chris Albanese
Mol Cancer Res September 1 2019 (17) (9) 1815-1827; DOI: 10.1158/1541-7786.MCR-19-0191
The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells
Erika Parasido, George S. Avetian, Aisha Naeem, Garrett Graham, Michael Pishvaian, Eric Glasgow, Shaila Mudambi, Yichien Lee, Chukwuemeka Ihemelandu, Muhammad Choudhry, Ivana Peran, Partha P. Banerjee, Maria Laura Avantaggiati, Kirsten Bryant, Elisa Baldelli, Mariaelena Pierobon, Lance Liotta, Emanuel Petricoin, Stanley T. Fricke, Aimy Sebastian, Joseph Cozzitorto, Gabriela G. Loots, Deepak Kumar, Stephen Byers, Eric Londin, Analisa DiFeo, Goutham Narla, Jordan Winter, Jonathan R. Brody, Olga Rodriguez and Chris Albanese
Mol Cancer Res September 1 2019 (17) (9) 1815-1827; DOI: 10.1158/1541-7786.MCR-19-0191
Jump to section
Advertisement